Explore Our Global Collection of Biospecimens

Acute Leptospira

Plasma, Plasma Na Citrate, Plasma EDTA K3

Tropical Disease Other Signs and Symptoms, Tropical Disease Signs and Symptoms

HAV RT-PCR, UltraQual 1000 2x

Albumin

Plasma, Serum

Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Elevated albumin (Alb) (laboratory evidence), Ethnicity, Gastroenterology Condition, Gender, Lipemia (laboratory evidence), Reported Age, Subject is 18 years of age or older at the time of enrollment and blood draw, Subject receiving treatment, Time of Draw, Treatment History, Treatment or Medication Start Date

Albumin, Cholesterol, HDL, Triglycerides

Alcoholic Cirrhosis

Plasma, Serum

Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), City of Origin, Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Elevated albumin (Alb) (laboratory evidence), Ethnicity, Gender, Lipemia (laboratory evidence), Reported Age, Subject is 18 years of age or older at the time of enrollment and blood draw, Subject receiving treatment, Time of Draw

NT-Pro BNP

Alcoholic Liver Disease

Plasma EDTA K3

Abbott Architect Anti HCV Result, Country of Origin, Date of Birth, Date of Draw, Date sample frozen at -20 C or colder, Ethnicity, Fibrosis Score (Choose One), Gender, Is the most recent liver biopsy result available?, Periportal Necroinflammatory Score (Choose one), Portal Inflammation Score (Choose one), Sample Storage Temperature, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one)

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, ALT, AST, Total Bilirubin, Total Protein

ALP

Serum

Cockroach, Mold

Serum

Immulite Allergy IgE

ALT

Plasma, Serum

Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Elevated albumin (Alb) (laboratory evidence), Ethnicity, Gastroenterology Condition, Gender, Lipemia (laboratory evidence), Reported Age, Subject is 18 years of age or older at the time of enrollment and blood draw, Subject receiving treatment, Time of Draw, Treatment or Medication Start Date

ALT, AST, T3

ANA

Plasma, Serum, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Ethnicity, Gender, Reported Age, Rheumatology Condition, Time of Draw, Treatment History

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Albumin, ANA, ANA IgG, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Calcium, CENTROMERE AB, Chloride (Cl), Cholesterol, CHROMATIN AB, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Direct Bilirubin, dsDNA AB, Immunoglobulin G, JO1-IGG- AB, NT-Pro BNP, Phosphorus, Potassium (K), Rheumatoid Factor, RNP AB, SCL70 AB, SM AB, Sodium (NA), SSA AB, SSB AB, Total Bilirubin, Total Protein, Triglycerides

Anti-Thyroglobulin

Serum

AST

Serum, Plasma EDTA K3

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, AST

Asymptomatic

Saliva, Serum SST, Nasopharyngeal swabs, Oropharyngeal Swab, Nasal Swab, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Gender, If pregnant, which trimester?, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Pre-Existing Medical Conditions, Reported Age, Time Frozen at -20 C or colder, Time of Draw, Vaccine manufacturer, Was the subject previously diagnosed with COVID-19?

AdviseDx SARS-CoV-2 IgM, Anti-Mullerian Hormone, Architect SARS-CoV-2 IgG, EURORealTime SARS-CoV-2, Follicle Stimulating Hormone, Luteinizing Hormone, Perkin Elmer SARS-CoV-2 SWAB

Scl-70, RNP, Jo-1, Guillain-Barre, ds-DNA, SSB, Hypothyroidism, Hyperthyroidism, SM, Autoimmune Hep., SSA, MPO

Plasma, Serum, Serum SST, Plasma EDTA K3

Abbott Architect Anti HCV Result, City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Drug use?, Ethnicity, Fibrosis Score (Choose One), Gender, If pregnant, which trimester?, Is the most recent liver biopsy result available?, Liver Biopsy Date Tested:, Periportal Necroinflammatory Score (Choose one), Portal Inflammation Score (Choose one), Pre-Existing Medical Conditions, Reported Age, Sample Storage Temperature, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Smoking History, Subject is 18 years of age or older at the time of enrollment and blood draw, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Vaccine manufacturer

ALT, Antineutrophil cytoplasmic antibodies, AST, dsDNA AB, Ferritin, JO1-IGG- AB, RNP AB, SCL70 AB, SM AB, Soluble Transferrin Receptor, SSA AB, SSB AB, Thyroglobulin

BV

Genital Swabs

Bilirubin-Direct, Bilirubin-Total

Serum, Plasma EDTA K3

Direct Bilirubin, T3-TOTAL

Blood Donor

Plasma

Blood Urea Nitrogen

Serum

Cadaveric

Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3

Cause of Death, Country of Origin, Date of Birth, Date of Death, Date of Draw, Date sample frozen at -20 C or colder, Ethnicity, Gender, If transfusion and/or infusion of crystalloids in less than 2,000mL, how many mL?, If transfusion or infusion of blood or colloids is less than 2,000mL, how many mL?, Reported Age, Sample Hemolysis Level (Qualtex Color Comparator), Time Between Death and Blood Draw (Minutes), Time Frozen at -20 C or colder, Time of Death, Time of Draw, Transfusion and/or Infusion of blood or colloids in excess of 2,000mL within 48 hours prior to collection of the blood specimen?, Transfusion and/or Infusion of crystalloids in excess of 2,000mL within 1 hours prior to collection of the blood specimen?

Abbott Anti-HBs (AUSAB), Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Anti-HCV EIA: (Ortho HCV 3.0 EIA Test System), Aptima Zika Virus Assay - Plasma, Aptima Zika Virus Assay - Serum, CMV Antibody IgG, CMV Antibody IgM, Genetic Systems HBsAg EIA 3.0, Hepatitis B Core Antibodies, Total, Hepatitis B Virus Surface Antibody, Hepatitis B Virus Surface Antigen, Hepatitis C Virus Antibody by CIA, HIV 1/2 ab, HIV-1/HCV/HBV Ultrio Screen, Hologic Panther SARS-CoV-2, Human Immunodeficiency Virus (HIV) Combo Antigen/Antibody (HIV-1/O/2) by CIA, Human T-Lymphotropic Virus (HTLV) Types I/II Antibodies by ELISA , Human T-Lymphotropic Virus Types I/II Antibodies, Western Blot, Liaison CMV IgG, Procleix Ultrio Elite Assay, Treponema pallidum Ab by TP-PA, Trypanosoma cruzi, IgG, Trypanosoma cruzi, IgM , WNV-PCR: (Roche WNV-PCR)

Calcium, Cadaveric

Serum, Plasma EDTA K3

Cause of Death, Country of Origin, Date of Death, Date of Draw, Date sample frozen at -20 C or colder, Ethnicity, Gender, If transfusion and/or infusion of crystalloids in less than 2,000mL, how many mL?, If transfusion or infusion of blood or colloids is less than 2,000mL, how many mL?, Reported Age, Time Between Death and Blood Draw (Minutes), Time Frozen at -20 C or colder, Time of Death, Time of Draw, Transfusion and/or Infusion of blood or colloids in excess of 2,000mL within 48 hours prior to collection of the blood specimen?, Transfusion and/or Infusion of crystalloids in excess of 2,000mL within 1 hours prior to collection of the blood specimen?

HIV-1/HCV/HBV Ultrio Screen

Cancer, Gastric Cancer, Uterine Cancer, Lip Cancer, Breast Cancer, Serosa Cancer, Intestine Cancer, Endometrial Cancer, Larynx Cancer, Esophageal Cancer, Testicular Cancer, Salivary Gland Cancer, Liver Cancer, Cervical Cancer, Lung Cancer, Kidney Cancer, Bladder Cancer, GEJ, Thyroid Cancer, Head and Neck Cancer, Sarcoidosis, Bone Cancer, Colon Cancer, Abdominal Cancer, Rectal Cancer, Prostate Cancer, Lymphoma, AML, SCLC, Lymph Node, Pelvic Tumor, Stomach Cancer, Gallbladder Cancer, Skin Cancer, Brain Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Cholangiocarcinoma, Melanoma, Penile Cancer, NSCLC

FFPE Tumor, Buffy Coat, WB PAXgene RNA, Plasma, Serum, WB EDTA K2, Whole Blood, Plasma cf-DNA, FFPE NAT, FFPE Metastasis, Slides, Buffy Coat cf-DNA, Plasma EDTA K3, Fresh Frozen Tissue, FFPE Tumor Curls

Alcohol use?, AML Diagnosis Test, Blast Count After Treatment, Blast Count before Treatment, Blood Testing , Cancer Related Markers, Clinical Diagnosis, Clinical Observations, comorbidities?, Concomitant Medications (if reported), Country of Origin, Current Medications (oncology), Date of Birth, Date of Blast Count after Treatment, Date of Blast Count before Treatment, Date of Diagnosis, Date of Draw, Date of Procedure, Date of Surgery, Date of Tissue Procurement, Description of Diagnosis, Diagnosis (Oncology), Distant metastasis location , Does the subject smoke?, Donor HBV Status, Donor HCV Status, Donor HIV Status, Donor Syphilis Status, Drug use?, Estrogen Receptor (ER) Testing, Ethnicity, Extent of spread to the lymph nodes (N), Extent of the tumor (T), FFPE Tumor from Primary Tumor Resection?, Gender, Grade of Cancer, Gross Description, Height (cm), HER2 Testing, Histologic Type, Hormonal therapy?, If pregnant, which trimester?, Lymph Node metastasis, Metastasis, Method of Verification, Minutes before fixation to Formalin, Months Pregnant?, Pathological Diagnosis, Pathology Report, Patient Outcome Data, Percent Necrosis, Pre-Existing Medical Conditions, Presence of metastasis (M), Previous Chemotherapy?, Primary or recurrent, Processing Start Date, Progesterone Receptor (PR) Testing, Reported Age, ROS1 IHC Score, Sample Storage Temperature, Site reported laboratory results, Smoking History, Specimen Type, Stage of Cancer, Start time of blood processing, Storage Start Date, Storage Start Time, Surgical History, Surgical Procedure, Time Frozen at -20 C or colder, Time of Draw, Time of Tissue Procurement, Tissue Size (cm), Treatment History, Treatment or Medication Start Date, Tumor Content (%), Tumor Description, Tumor Size (cm), Tumour Location, Type of Collection Tube, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, ACVR2A, BTBD7, DID07, DIDO1, HIV 1/2 ab, Microsatellite Instable, MRE11, PD-L1 28-8 IHC, RYR3, SEC31A, SULF2, Tissue Quality Check

Carbon Dioxide

Serum

Cardiac

WB EDTA K2, Whole Blood

ACE inhibitors or ARBs, Beta Blockers, Cardiovascular Disease Event (CVD), Clot preventing drugs, Concomitant Medications (if reported), Date of Cardiovascular Disease Event (CVD), Date of Draw, Statins, Surgical History, Treatment or Medication Start Date

CSF

CSF

Clinical Diagnosis

Adenosine Deaminase, Alpha-Fetoprotein, ANA, ANA IgG, Anti-Glomerular Basement Membrane Disease IgG, CA-125, CA19-9, Carcinoembryonic antigen (CEA), Cell Count , CMV IgG, CMV IgM, Cryptococcus Ag, dsDNA AB, EBV IgM, EBV VCA IgG, ENA-6 Panel, HBV, HBeAg, Hepatitis B Core Ab, HIV, HIV 1/2 ab, HSV-1 IgG, HSV-1 IgM, HSV-2 IgG, HSV-2 IgM, HTLV I/II , Lactic Acid Dehydrogenase, P-anca, Protein (Total), PSA (Prostatic Specific Antigen), Rubella IgG, Rubella IgM, Total Protein, Toxoplasma IgG, Toxoplasma IgM, Treponema

Chagas

Saliva, Plasma, Serum, Whole Blood, Urine

Date of onset of first symptoms, Pregnant?, Subject is 18 years of age or older at the time of enrollment and blood draw, Suspected Tropical Disease, Tropical Disease Other Signs and Symptoms, Tropical Disease Signs and Symptoms

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Anti-T. cruzi EIA: (Ortho T. cruzi ELISA Test System), Aptima Zika Virus Assay - Serum, Chagatest HAI, DiaPro Anti-Chikungunya IgG, DiaPro Zika Virus IgG, DiaSorin Zika IgM, InBios Anti-Dengue IgG, InBios Anti-Dengue IgM, InBios Chikungunya IgM, InBios Zika IgM Capture , Trypanosoma cruzi, IgG, Trypanosoma cruzi, IgM

Chloride

Serum

Chloride (Cl)

Cholesterol

Serum

CMV IgM, CMV

Plasma, Serum, Plasma EDTA K2

Concomitant Medications (if reported), Country of Origin, Date of Draw, Ethnicity, Gender, Height (cm), Reported Age, Start time of blood processing, Storage Start Date, Storage Start Time, Time of Draw, Treatment or Medication End Date, Treatment or Medication Start Date, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, CMV Antibody IgM, CMV IgG, CMV IgM, CMV PCR

COVID-19 Vaccination, COVID-19 Symptomatic, COVID-19 Asymptomatic, COVID-19 Variants (sequenced)

Serum Non-SST, SalivaBio Saliva, Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, DBS (Finger Prick), Serum SST, Nasopharyngeal swabs, Dry NP Swab, Norgen OP Swab, Oropharyngeal Swab, Saline, Spectrum DNA Saliva, OraSure Saliva, Nasal Swab, Plasma Na Citrate, DNA Genotek Saliva, UTM, Plasma EDTA K3, VTM NPS

Amino Acid Deletions, Amino Acid Insertions, Amino Acid Substitutions, Change in Concomitant Medications? , Change in underlying medical conditions and/or risk behavior?, City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Molecular Test Manufacturer, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date DBS finger prick frozen at -20 C or colder, Date DBS venous frozen at -20 C or colder, Date Mechanical Ventilation Stopped, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Death, Date of Diagnosis, Date of discharge from hospital?, Date of Discharge from ICU, Date of Draw, Date of hospitalization, Date of ICU Admission, Date of onset of first symptoms, Date of Symptom Resolution, Date sample frozen at -20 C or colder, Day(s) subject received mechanical ventilation (MV) / Intubation, Did subject receive a covid-19 vaccine booster?, Did the subject develop longer effects of COVID-19 treatment or hospitalization?, Did the subject develop pneumonia, Did the subject have a multi organ system effect due to COVID-19?, Did the subject have acute respiratory distress syndrome, Did the subject have an abnormal Chest X-ray, Did the subject have an abnormal EKG, Did the subject have another diagnosis or etiology for their illness?, Did the subject receive a covid-19 vaccination, Did the subject receive ECMO, Did the subject Receive invasive Ventilation, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Did the subject Receive non-invasive Ventilation (NIV), Did the Subject Receive Other Therapeutic Interventions?, Did the subject receive supplemental oxygen?, Did the subject's symptoms resolve?, Ethnicity, Fever Temperature (F), Gender, If pregnant, which trimester?, If yes, specify illness, If Yes, specify the affected organ(s), if Yes, specify the effect(s), If yes, total days with NIV, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Is the subject a healthcare worker?, Location of the Worker's Health Center, Nucleotide Deletions, Nucleotide Insertions, Nucleotide Substitutions, pangoLEARN version, Patient Outcome Data, Percent of Genome Coverage, Pre-Existing Medical Conditions, Reported Age, Sample Hemolysis Level (Qualtex Color Comparator), SARS-CoV-2 Nextstrain Clade, SARS-CoV-2 PANGOLIN Lineage, SARS-CoV-2 Variant Common Name, Sequencing reference genome (GenBank Accession), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Symptomology at the Time of Diagnosis, Test Date (site reported results), Test Manufacturer, Time DBS finger prick frozen at -20 C or colder, Time DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder, Time of Centrifugation, Time of DBS finger prick, Time of DBS venous, Time of Draw, Time of finger prick, Total days with supplemental oxygen, Vaccine manufacturer, Was the subject admitted to the intensive care unit (ICU)?, Was the subject attending rehabilitation sessions?, Was the subject diagnosed with COVID-19 since the last visit?, Was the subject hospitalized?, Was the subject previously diagnosed with COVID-19?

Abbott Anti-HCV , Abbott Architect Procalcitonin, Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Adenovirus Antibody, Serum, AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG, B. pertussis Ab, IgA by ELISA, B. pertussis Ab, IgM by ELISA, Bordetella pertussis Antibody, IgA by Immunoblot, Bordetella pertussis Antibody, IgG by Immunoblot, Bordetella pertussis Antibody, IgM by Immunoblot, Coxsackie A9 Virus Antibodies, Coxsackie B Virus Antibody Type 1, Coxsackie B Virus Antibody Type 2, Coxsackie B Virus Antibody Type 3, Coxsackie B Virus Antibody Type 4, Coxsackie B Virus Antibody Type 5, Coxsackie B Virus Antibody Type 6, cPass™ SARS-CoV-2 Neutralization kit., Echovirus Antibody Type 11, Echovirus Antibody Type 30, Echovirus Antibody Type 6, Echovirus Antibody Type 7, Echovirus Antibody Type 9, EDI COVID-19 IgM, EuroImmun COVID-19 IgA, EuroImmun COVID-19 IgG, Ferritin, Haemophilus influenzae b Antibody, IgG, Hepatitis B Virus Surface Antigen, Hepatitis C Virus Antibody by CIA, HIV 1/2 ab, Hologic Panther Fusion SARS-CoV-2/Flu A/B/RSV, Hologic Panther SARS-CoV-2, Human Immunodeficiency Virus (HIV) Combo Antigen/Antibody (HIV-1/O/2) by CIA, InBios SARS-CoV-2 IgG, InBios SARS-CoV-2 IgM, Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, Influenza B Virus Antibody IgG, Influenza B Virus Antibody IgM, Iron, Serum or Plasma, Liaision SARS-CoV-2 Ab, Liaison SARS-CoV-2 IgM, LIAISON XL SARS-CoV-2 S1/S2 , Mycoplasma Pneumoniae Antibody IgG, Mycoplasma Pneumoniae Antibody IgM, NovaTek Parainfluenza Virus 1, 2, 3 IgG, NovaTek RSV IgG ELISA, Perkin Elmer SARS-CoV-2 SALIVA, Perkin Elmer SARS-CoV-2 SWAB, PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel Assay, PolioVirus Antibody Type 1, PolioVirus Antibody Type 3, RPR (Rapid Plasma Reagin) , Soluble Transferrin Receptor, Syphilis, TaqPath SARS-CoV-2, Thyroid Stimulating Hormone

Creatinine

Serum, Serum SST

City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of discharge from hospital?, Date of Draw, Date of hospitalization, Date of onset of first symptoms, Day(s) subject received mechanical ventilation (MV) / Intubation, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Ethnicity, Fever Temperature (F), Gender, If pregnant, which trimester?, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Is the subject a healthcare worker?, Location of the Worker's Health Center, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Symptomology at the Time of Diagnosis, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Was the subject hospitalized?

AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG, LIAISON XL SARS-CoV-2 S1/S2

Crohns Disease

Serum SST, Plasma EDTA K3

City of Origin, Clinical Symptom Score (CD: CDAI), Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of CRP result, Date of Diagnosis, Date of Draw, Date of FCP Result, Date sample frozen at -20 C or colder, Disease Status at time of sample collection, Ethnicity, Gastroenterology Condition, Gender, If on medications, for how long? (days), Is the subject currently on medications?, Most recent C-reactive protein (CRP) result, Most recent Fecal Calprotectin (FCP) result, Prior Biologic Treatment History, Reported Age, Subject is 18 years of age or older at the time of enrollment and blood draw, Time Frozen at -20 C or colder, Time of Draw

Ferritin, Soluble Transferrin Receptor

Cryptococcus

Serum

Cryptococcus Ag

Symp. DNV Adult, Dengue, Symp. DENV Pregnant, Symp. DENV Pediatric

Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, WB EDTA K2, Whole Blood, Serum SST, Urine, Plasma Na Citrate, Plasma EDTA K3

Body Mass Index, City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date of site reported dengue testing, Date sample frozen at -20 C or colder, Diastolic Blood Pressure, Does the patient have diagnostic testing?, Does the patient have yellow fever vaccination documentation?, Ethnicity, Fever Temperature (F), Gender, Has the subject been previously diagnosed with Dengue?, Has the subject presented with severe signs and symptoms for Dengue?, Height (cm), History of Diabetes?, If pregnant, which trimester?, If previously diagnosed with Dengue, which serotype?, Infection Status, Is the subject currently on medications?, Is the subject still currently symptomatic for Dengue?, Patient Has Documentation For Yellow Fever Vaccination, Pre-Existing Medical Conditions, Pregnant?, Severe Organ Involvement?, Severe Plasma Leakage?, Site Reported Dengue IgM, Site Reported Dengue Testing Performed?, Smoking History, Subject has high fever and at least two tropical disease signs and symptoms, Subject is 18 years of age or older at the time of enrollment and blood draw, Suspected Tropical Disease, Systolic Blood Pressure, Test Manufacturer, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Tropical Disease Other Signs and Symptoms, Tropical Disease Signs and Symptoms, Weight, kg

Abbott Anti-HCV , Abbott HB Core, Abbott HBc IgM, Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Adenovirus Antibody, Serum, AdviseDx SARS-CoV-2 IgM, Altona Dengue PCR, Altona Dengue Subtype, Aptima Zika Virus Assay - Plasma, Aptima Zika Virus Assay - Serum, Architect SARS-CoV-2 IgG, BinaxNOW Malaria, Bordetella pertussis Antibody, IgG by ELISA, C. pneumoniae IgG, C. pneumoniae IgM Titer, C. psittaci IgG, C. psittaci IgM , C. trachomatis IgG, C. trachomatis IgM, Chikungunya Antibody, IgG, Chikungunya Antibody, IgM, COBAS AmpliPrep HIV-1 Test, COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), Dengue Fever Virus Antibody, IgG , Dengue Fever Virus Antibody, IgM, Dengue Virus (1-4) Subtype by PCR, DiaPro Anti-Chikungunya IgG, DiaPro Anti-Chikungunya IgM, DiaPro Zika Virus IgG, DiaSorin Zika IgM, EuroImmun Anti-Chikungunya Virus IgG, EuroImmun Anti-Chikungunya Virus IgM, EuroImmun Anti-Dengue Virus IgG, EuroImmun Anti-Dengue Virus IgM, EuroImmun Anti-Zika Virus IgG, Haemophilus influenzae b Antibody, IgG, Human Chorionic Gonadotropin (hCG), InBios Anti-Dengue IgG, InBios Anti-Dengue IgM, InBios Chikungunya IgG, InBios Chikungunya IgM, InBios Dengue NS-1, InBios WNV IgM, InBios Zika IgM Capture , Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, Influenza B Virus Antibody IgG, Influenza B Virus Antibody IgM, Liaison CMV IgG, Liaison CMV IgM, Liaison SARS-CoV-2 IgM, LIAISON XL SARS-CoV-2 S1/S2 , Malaria Detection and Speciation, Qualitative by RT PCR, Mycoplasma Pneumoniae Antibody IgG, Mycoplasma Pneumoniae Antibody IgM, Trypanosoma cruzi, IgG, West Nile Virus Antibody, IgG by ELISA, Serum, West Nile Virus Antibody, IgM by ELISA, Serum, Zika Virus IgM Antibody Capture (MAC), by ELISA, ZIKV Detect 2.0 IgM Capture ELISA

Dialysis

Plasma, Serum, Serum SST, Dialyzate Fluid, Urine, Plasma EDTA K3

Blood Counts, Creatine, Date of Death, Date of Draw, Date of first dialysis, Days subject undergoes dialysis, How long (hours) is each Dialysis procedure? , Time of Death, Time of Draw

Abbott Anti-HCV , Abbott Architect Procalcitonin, Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, C-Reactive Protein, NT-Pro BNP, Parathyroid Hormone, Intact, Thyroxine, Thyroxine, Free (Free T4), Triiodothyronine, Free (Free T3)

EBV IgG, EBV VCA IgM, EBV

Plasma, Serum, Plasma EDTA K2, Plasma EDTA K3

Concomitant Medications (if reported), Country of Origin, Date of Draw, Ethnicity, Gender, Height (cm), Reported Age, Start time of blood processing, Storage Start Date, Storage Start Time, Time of Draw, Treatment or Medication End Date, Treatment or Medication Start Date, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, EBV by Qualitative PCR, EBV by Quantitative PCR, EBV VCA IgG, Epstein-Barr Virus Ab to Early D Antigen, IgG, Epstein-Barr Virus Ab to Nuclear antigen, Igg, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM

End-stage Cirrhosis

Serum SST, Plasma EDTA K3

Abbott Architect Anti HCV Result, City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did the subject receive a covid-19 vaccination, Ethnicity, Fibrosis Score (Choose One), Gender, If pregnant, which trimester?, Is the most recent liver biopsy result available?, Liver Biopsy Date Tested:, Periportal Necroinflammatory Score (Choose one), Portal Inflammation Score (Choose one), Pre-Existing Medical Conditions, Reported Age, Sample Storage Temperature, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Vaccine manufacturer

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Alanine Aminotransferase, Albumin, Serum or Plasma, Alkaline Phosphatase, ALT, ANA, IgG by IFA, Anion Gap, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Aspartate Aminotransferase, AST, Bilirubin, Total, Serum or Plasma, Calcium, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Chloride, Serum or Plasma, Creatinine, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Ferritin, Glucose, Serum or Plasma, Potassium, Serum or Plasma, Protein Total, Serum/Plasma, Rheumatoid Factor, Sodium, Serum or Plasma, Soluble Transferrin Receptor, Total Bilirubin, Total Protein, Urea Nitrogen, Serum or Plasma

Febrile Pediatric

Serum SST

Ferritin

Serum

Ferritin

B12

Plasma Na Heparin, Serum, Plasma Lithium Heparin

ALT, B12, Vitamin B12

Gentamicin

Serum

GI

Rectal Swab, Cairy blair stool

Date of Consent, Date of Draw, Gender, Infant Age, Reported Age

BioFire FilmArray Gastrointestinal (GI) Panel

Glucose

Serum

Graves' Disease

Serum SST

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Gender, If pregnant, which trimester?, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Vaccine manufacturer

Alanine Aminotransferase, Albumin, Serum or Plasma, Alkaline Phosphatase, ANA, IgG by IFA, Anion Gap, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Aspartate Aminotransferase, Bilirubin, Total, Serum or Plasma, Calcium, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Chloride, Serum or Plasma, Creatinine, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Ferritin, Glucose, Serum or Plasma, Potassium, Serum or Plasma, Protein Total, Serum/Plasma, Rheumatoid Factor, Sodium, Serum or Plasma, Thyroid Stimulating Immunoglobulin, Urea Nitrogen, Serum or Plasma

HAVPL, HAV Vaccination, Acute HAV, HAV

Saliva, WB PAXgene RNA, Plasma, Serum, Plasma EDTA K2, Whole Blood, Serum SST, Urine, Plasma Na Citrate, Plasma EDTA K3, Plasma PPT EDTA K2

Alcohol use?, City of Origin, Clinical Observations, comorbidities?, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date of Vaccine Administration, Date sample frozen at -20 C or colder, Does the patient have diagnostic testing?, Donor HBV Status, Donor HCV Status, Donor HIV Status, Ethnicity, Gender, Height (cm), Patient Has Documentation For Yellow Fever Vaccination, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Start time of blood processing, Storage Start Date, Storage Start Time, Subject is 18 years of age or older at the time of enrollment and blood draw, Subject receiving treatment, Suspected Tropical Disease, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Tropical Disease Other Signs and Symptoms, Tropical Disease Signs and Symptoms, Vaccine manufacturer, Vaccine Name, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Architect Anti-HAV IgG, Architect Anti-HAV IgM, AST, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, EBV by Qualitative PCR, Genetic Systems HBsAg EIA 3.0, HAV RT-PCR (AmpliSens PCR Kit), HAV RT-PCR, UltraQual 1000 2x, Liaison Anti-HAV, Syphilis MHA-TP, WNV-PCR: (Roche WNV-PCR)

HBcIgM, HBcAb, HBV, HBeAg, HBsAg

Serum Non-SST, Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma CPD, Plasma Na Citrate, Plasma EDTA K3, Plasma PPT EDTA K2

Biopsy performed?, City of Origin, Clinical state of Hepatitis B infection, Country of Origin, Current HBV Medications (please check all types that apply):, Date of Birth, Date of Consent, Date of Diagnosis, Date of Diagnosis of Hepatitis B Infection, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Date tested (Liver biopsy), Description of Diagnosis, Ethnicity, Extent of spread to the lymph nodes (N), Extent of the tumor (T), Extraction (Internal) Control Coverage, Fever Temperature (F), Gender, HBV Genotype test performed?:, Histologic Type, If on medications, for how long? (days), If pregnant, which trimester?, If yes, date performed ( HBV Genotype test performed), If yes, date performed (Biopsy performed), If Yes, How long? years months, If yes, result: (Anti H Be test performed), If yes, result: (HBV Genotype test performed), If yes, stage of biopsy (Biopsy performed), Infection Status, Integrase amplicon coverage, Integrase Mutations, Method of Verification, Presence of metastasis (M), Protease Mutations, Protease RT amplicon coverage, Reported Age, Risk Factors, RT Mutations, Signs and Symptoms at the Time of Draw., Stage of Cancer, Subject is 18 years of age or older at the time of enrollment and blood draw, Symptomology at the Time of Diagnosis, Time Frozen at -20 C or colder, Time of Draw, Tumor Size (cm), Tumour Location

Abbott Anti-HBs (AUSAB), Abbott Anti-HCV , Abbott HB Core, Abbott HBc IgM, Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Bio-Rad BioPlex 2200 HIV Ag-Ab, COBAS AmpliPrep HIV-1 Test, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, COBAS Ampliprep/TaqMan 48 HBV, v2.0, DiaSorin Anti-HBe, DiaSorin HBeAg, Genetic Systems HBsAg EIA 3.0, HBV BCP Mutations, HBV Mutations: Other, HBV Polymerase Mutations, HBV Precore (TAG) Mutations, HBV Precore Mutations, Hepatitis B Core Antibodies, Total, Hepatitis B Virus Core Antibody, IgM, Hepatitis B Virus Genotype by Sequencing, Hepatitis B Virus Surface Antibody, Hepatitis Be Virus Antibody, Hepatitis Be Virus Antigen, Hepatitis C Viral RNA LiPA, Immunoglobulin G, Liaison CMV IgG, Liaison CMV IgM, n/a, PRISM HBsAg, Quest Diagnostics HBV Genotyping LDT, Quest Diagnostics HIV Genotype, Quest HBV_Genotype, TRUGENE HBV genotyping assay_Siemens Medical Solutions Diagnostics, VelaDX Sentosa SQ HIV-1 Genotyping Assay, Versant HBV bDNA 3.0

HCV GT 5, HCV GT 2B, HCV GT 4A, HCV Ag, HCV GT 4, HCV GT 4C, HCV GT 3A, HCV IgM, HCV GT 6, HCV GT 4E, HCV, HCV GT 3B

Plasma ACD-A, Plasma, Serum, Plasma CPDA, Serum SST, Plasma CPD, Plasma EDTA K3

Biopsy performed?, City of Origin, Clinical State of Hepatitis C Infection, Concomitant Medications (if reported), Country of Origin, Current HCV Medications (Select all that apply), Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Date tested (Liver biopsy), Ethnicity, Fibrosis Score, Gender, Genotype and Subtype (HCV Genotype), HCV Genotype / Subtype Test performed?, HCV Viral Load Performed (within last 90 days), If pregnant, which trimester?, If yes, date performed? (HCV Genotype), If yes, stage of biopsy (Biopsy performed), Reported Age, Sample Hemolysis Level (Qualtex Color Comparator), Test Manufacturer, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Treatment or Medication Start Date

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Anti-HCV IgG cor (Vitro-Test_Ukraine), Anti-HCV IgG NS3 (Vitro-Test_Ukraine), Anti-HCV IgG NS4 (Vitro-Test_Ukraine), Anti-HCV IgG NS5 (Vitro-Test_Ukraine), Aptima HCV Viral Load, Bayer VERSANT HCV RNA 3.0, Bio-Rad BioPlex 2200 HIV Ag-Ab, COBAS AmpliPrep COBAS TaqMan HCV Test v2.0, COBAS AmpliPrep HIV-1 Test, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, COBAS Ampliprep/TaqMan 48 HBV, v2.0, COBAS Ampliprep/TaqMan 48 HIV-1, v2.0, COBAS Ampliprep/TaqMan48 HCV, v2.0, eSensor HCVg Direct test, Ferritin, Hep C Virus by Quant PCR , Hep C Virus Genotyping, Hepatitis B Core Antibodies, Total, Hepatitis B Virus Core Antibody, IgM, Hepatitis B Virus Surface Antibody, Hepatitis Be Virus Antibody, Hepatitis Be Virus Antigen, Hepatitis C IgM (Vitro-Test_Ukraine), Hepatitis C Viral RNA LiPA, Immunoglobulin G, INNO-LiPA HCV Genotype, Liaison CMV IgG, Liaison CMV IgM, Ortho HCV Version 3.0 ELISA Test System, PRISM HBsAg, Procleix Ultrio Plus, Quest Diagnostics HBV Genotyping LDT, Soluble Transferrin Receptor, Total Bilirubin, Total Protein, Versant HCV RNA ASSAY (bDNA) 3.0

IgM, Total Antibodies, HDV

Serum

Date of Draw, Ethnicity, Gender, Reported Age

Hepatitis D Total Antibodies, Hepatitis D Virus PCR AmpliSens , Hepatitis D, IgM

Helicobacter pylori

Plasma, Plasma EDTA K2

Identity of Bacterial Infection

H.pylori

HEV, HEV IgM

Plasma, Serum

Hepatitis E Virus (HEV) Antibody, IgG, Hepatitis E Virus (HEV) Antibody, IgM, Hepatitis E Virus (HEV) IgM

HGV

Serum

Hepatitis G Virus PCR

HR HIV, HIV-2, Adult High Risk, HR HCV, HR HIV Preg, High Risk, HR HBV, High Risk HIV-2, HCV

Plasma, Serum, Plasma EDTA K2, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Draw, Date sample frozen at -20 C or colder, Ethnicity, Fibrosis Score (Choose One), Gender, HCV Risk Factors, If pregnant, which trimester?, Is the most recent liver biopsy result available?, Periportal Necroinflammatory Score (Choose one), Portal Inflammation Score (Choose one), Sample Hemolysis Level (Qualtex Color Comparator), Sample Storage Temperature, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Alanine Aminotransferase, Albumin, Serum or Plasma, Alkaline Phosphatase, ALT, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Aspartate Aminotransferase, AST, Bilirubin, Total, Serum or Plasma, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Direct Bilirubin, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Ferritin, Free PSA (Prostatic Specific Antigen), Free T3, Free T4, FSH, Hepatitis A Virus Antibodies (Total), Hepatitis B Core Antibodies, Total, Hepatitis B Virus Core Antibody, IgM, Hepatitis B Virus Surface Antibody, Hepatitis Be Virus Antibody, Hepatitis Be Virus Antigen, hGH, HIV-1 Viral Load, Human Chorionic Gonadotropin (hCG), Insulin-Like Growth Factor (IGF-1), Liaison CMV IgG, LIAISON Measles IgG, LIAISON Mumps IgG, LIAISON Rubella IgG, Luteinizing Hormone (LH), NT-Pro BNP, Progesterone II Gen, Prolactin, Prostatic Specific Antigen, Total, Protein Total, Serum/Plasma, PSA (Prostatic Specific Antigen), Rheumatoid Factor, Soluble Transferrin Receptor, Testosterone, Total Bilirubin, Total Protein, TSH, Varicella-Zoster Virus Antibody, IgG, Zeptometrix HIV-1 p24 Antigen

HIV-G, HIV-O, HIV-2, HIV-1, HIV, High Risk HIV-2, HIV-0

Serum Non-SST, WB EDTA K3, Plasma, Serum, WB EDTA K2, Plasma EDTA K2, DBS (Finger Prick), Serum SST, WB Na Heparin, WB Greiner PPT, Plasma CPD, WB Serum, DBS (Venous), Plasma Na Citrate, Plasma Lithium Heparin, Plasma EDTA K3, Human Cord Serum

Alcohol use?, Before HIV diagnosis, this child had, Biological Mothers HIV Status, Blood Type, City of Origin, Combination HIV medicines, comorbidities?, Concomitant Medications (if reported), Country of Origin, COVID-19 Molecular Test Manufacturer, Current HIV Medications (please check all types that apply):, Date DBS finger prick frozen at -20 C or colder, Date DBS venous frozen at -20 C or colder, Date of Birth, Date of Consent, Date of DBS finger prick, Date of DBS venous, Date of Diagnosis, Date of discharge from hospital?, Date of Discharge from ICU, Date of Draw, Date of finger prick, Date of HIV diagnosis, Date of hospitalization, Date of ICU Admission, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Day(s) subject received mechanical ventilation (MV) / Intubation, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Did the Subject Receive Other Therapeutic Interventions?, Did the subject receive supplemental oxygen?, Donor HIV Status, Ethnicity, Extraction (Internal) Control Coverage, Fever Temperature (F), Fusion Inhibitors, Gender, Has the Subject ever received treatment for HIV infection, Height (cm), HIV Risk Factors, HIV-1 & HIV-2 Antibody differentiation assay name, HIV-1 & HIV-2 Antibody differentiation test date, HIV-1 & HIV-2 Antibody differentiation test manufacturer, HIV-1 & HIV-2 Antibody differentiation test preformed, HIV-1 & HIV-2 Antibody differentiation test result, If no has the subject been on previous antiretroviral medication?, If pregnant, which trimester?, If Yes, How long? months years, If Yes, How long? years months, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Integrase amplicon coverage, Integrase Inhibitors, Integrase Mutations, Is the subject a healthcare worker?, Non-nucleoside Reverse Transcriptase Inhibitors (NRTIs), Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Pharmacokinetic Enhancers, Pre-Existing Medical Conditions, Previous HIV Medications, Protease Inhibitors (PIs), Protease Mutations, Protease RT amplicon coverage, Reported Age, RT Mutations, Sample Hemolysis Level (Qualtex Color Comparator), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Subject is 18 years of age or older at the time of enrollment and blood draw, Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Subject receiving treatment, Symptomology at the Time of Diagnosis, Test Date (site reported results), Test Manufacturer, Time DBS finger prick frozen at -20 C or colder, Time DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder, Time of Centrifugation, Time of DBS finger prick, Time of DBS venous, Time of Draw, Time of finger prick, Total days with supplemental oxygen, Was the subject admitted to the intensive care unit (ICU)?, Was the subject hospitalized?, Weight, kg

Abbott Anti-HCV , Abbott HB Core, Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Real Time HIV-1 , Abbott Syphilis TP, AST, Beta-hCG, Serum Qualitative, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Bio-Rad GEENIUS TEMPORARY CODE, Bio-Rad Genie II HIV-1/HIV-2, Bio-Rad Genie III HIV-1 Ab, Bio-Rad Genie III HIV-2 Ab, CMV Antibody IgG, CMV Antibody IgM, COBAS AmpliPrep COBAS TaqMan HIV-1 Test_Roche Molecular Systems, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, COBAS Ampliprep/TaqMan 48 HIV-1, v2.0, Cobas TaqScreen West Nile Virus, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Genetic Systems HBsAg EIA 3.0, HIV 1/2 ab, HIV-1 by Quantitative PCR, HIV-1 Viral Load, HIV-2 Qual NAT, HIV-2 Quant NAT, HIV-2 RNA PCR NAT, HIV-2 RNA Viral Load, HIV-2 SuperCycle Assay, Immunoglobulin G, InBios WNV IgG, InBios WNV IgM, Liaison CMV IgG, Liaison CMV IgM, LIAISON Measles IgG, LIAISON Mumps IgG, LIAISON Rubella IgG, n/a, PRISM HBsAg, Quest Diagnostics HIV Genotype, Soluble Transferrin Receptor, Syphilis , Total Bilirubin, Total Protein, Toxoplasma gondii Antibody, IgG, Varicella-Zoster Virus Antibody, IgG, VelaDX Sentosa SQ HIV-1 Genotyping Assay, Versant HIV-1 RNA 3.0 (bDNA), WNV-PCR: (Roche WNV-PCR), Zeptometrix HIV-1 p24 Antigen

Prolactin, BNP, Testosterone, AMH, Free T3, Total T3, 25 OH Vitamin D, TSH, Free T4, Total T4

Serum CAT, Saliva, Serum, Plasma EDTA K2, Plasma Lithium Heparin

Country of Origin, Date of Draw, Ethnicity, Gender, Reported Age

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Anti-Mullerian Hormone, DiaSorin Zika IgM, Direct Bilirubin, Free T3, Free T4, NT-proBNP, Parathyroid Hormone, Intact, Prolactin, T3, T3-TOTAL, T4, Testosterone, Thyroxine, Free (Free T4), Total T4, Triiodothyronine, Free (Free T3), TSH, Vitamin D-25

Emergency Department, Clostridium difficile, Hospital ICU Sepsis, Elevated WBC, Hospital Patient

Plasma, Serum, WB EDTA K2, BAL, Urine, Plasma Lithium Heparin, CSF, Stool liquid, Sputum

Abbott Architect Procalcitonin, Alkaline Phosphate, ALT, BUN, Clostridium difficile, CMV PCR, Creatine, FilmArray RespComplete Panel, InBios Zika IgM Capture , Procalcitonin, Triglycerides, TSH

All Comers

Swabs

City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Ethnicity, Gender, If pregnant, which trimester?, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Symptomology at the Time of Diagnosis, Time Frozen at -20 C or colder, Time of Draw

HSV-1, HSV-2, HSV

Plasma, Serum, Plasma EDTA K2, Aptima Vaginal Swab, Aptima Swabs

Concomitant Medications (if reported), Country of Origin, Date of Draw, Does the subject smoke?, Donor Blood Type, Ethnicity, Gender, Height (cm), Reported Age, Start time of blood processing, Storage Start Date, Storage Start Time, Time of Draw, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Herpes Simplex Virus (HSV-1/HSV-2) Subtype, HSV Type 1 and/or 2 Ab, IgM by ELISA, HSV Type 1 Glycoprotein G-Specific Ab, IgG by CIA, HSV Type 2 Glycoprotein G-Specific Ab, IgG by CIA, HSV-1 DNA PCR, HSV-1 IgM, HSV-2 DNA PCR, HSV-2 IgM

HTLV

Plasma, Serum SST, Plasma EDTA K3

City of Origin, Country of Origin, Date of Birth, Date of Consent, Date of Draw, Ethnicity, Gender, Signs and Symptoms at the Time of Draw., Stage of ATL, Subject has symptom / diagnosis of HAM / TSP, Subject is at increased risk for HTLV infection. Check one or more of the following risk factors., Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, HTLV I IFA_State of California Department of Public Health, HTLV I/II EIA_State of California Department of Public Health, HTLV II IFA_State of California Department of Public Health, Human T-Lymphotropic Virus (HTLV) Types I/II Antibodies by ELISA , Human T-Lymphotropic Virus Types I/II Antibodies, Western Blot

Hyperglobulinemia

Plasma EDTA K3

Hyperglobulinemia IgG, Hyperglobulinemia IgM

IgA, IgE

Serum

Atellica total Immunoglobulin E, Total Immunoglobulin A, Total Immunoglobulin E

Increased Risk HIV-2, Increased Risk HCV, Increased Risk Hep, Inc. Risk HCV Ped., Increased Risk HIV-1

Serum Non-SST, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of centrifugation, Date of Consent, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Ethnicity, Gender, HCV Risk Factors, If pregnant, which trimester?, Is the subject currently experiencing symptoms of hepatitis infection, Pre-Existing Medical Conditions, Reported Age, Risk Factors, Sample Hemolysis Level (Qualtex Color Comparator), Signs and Symptoms at the Time of Draw., Subject is 18 years of age or older at the time of enrollment and blood draw, Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Subject is not at increased risk for HIV-1 infection., Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Alkaline Phosphatase, ALT, AST, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Bordetella pertussis Antibody, IgG by ELISA, CMV Antibody IgG, CMV Antibody IgM, Direct Bilirubin, Ferritin, Free PSA (Prostatic Specific Antigen), Free T3, Free T4, FSH, Hepatitis A Virus Antibodies (Total), Hepatitis B Core Antibodies, Total, Hepatitis B Virus Core Antibody, IgM, Hepatitis B Virus Surface Antibody, Hepatitis Be Virus Antibody, Hepatitis Be Virus Antigen, Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG, hGH, HIV-1 Viral Load, Human Chorionic Gonadotropin (hCG), Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, Influenza B Virus Antibody IgG, Influenza B Virus Antibody IgM, Insulin-Like Growth Factor (IGF-1), Liaison CMV IgG, Liaison CMV IgM, LIAISON H. pylori IgG, LIAISON Mumps IgG, LIAISON Rubella IgG, Luteinizing Hormone (LH), Mycoplasma Pneumoniae Antibody IgG, Mycoplasma Pneumoniae Antibody IgM, Progesterone II Gen, Prolactin, Prostatic Specific Antigen, Total, PSA (Prostatic Specific Antigen), Rubella Antibody, IgG, Testosterone, Total Bilirubin, Toxoplasma gondii Antibody, IgG, TSH, Varicella-Zoster Virus Antibody, IgG, Varicella-Zoster Virus Antibody, IgM, Zeptometrix HIV-1 p24 Antigen

Increased Risk HAV

Serum SST, Plasma EDTA K3

Country of Origin, Date of Birth, Date of Draw, Ethnicity, Gender, Subject is at increased risk of Hepatitis A. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable:

Architect Anti-HAV IgM

Flu Vaccine, Influenza B, Influenza, Influenza A

WB EDTA K3, Serum, Whole Blood, Serum SST, Nasopharyngeal swabs, VTM, Saline, Nasal Swab, Plasma EDTA K3, VTM NPS

Amino Acid Deletions, Amino Acid Insertions, Amino Acid Substitutions, Change in Concomitant Medications? , Change in underlying medical conditions and/or risk behavior?, City of Origin, Clinical Observations, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of influenza diagnosis:, Date of onset of first symptoms, Date of previous COVID-19 diagnosis, Date of Seasonal Influenza Vaccine, Date of Vaccine Administration, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Did the subject receive a flu vaccine for this season?, Ethnicity, Fever Temperature (F), Gender, Has the Subject been Diagnosis with influenza in the last 2 years?, History of Flu Vaccine Administration, If pregnant, which trimester?, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Influenza vaccine manufacturer, Nucleotide Deletions, Nucleotide Insertions, Nucleotide Substitutions, pangoLEARN version, Percent of Genome Coverage, Pre-Existing Medical Conditions, Reported Age, Sample Source for Site Reported Lab Results, SARS-CoV-2 Nextstrain Clade, SARS-CoV-2 PANGOLIN Lineage, SARS-CoV-2 Variant Common Name, Sequencing reference genome (GenBank Accession), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Symptomology at the Time of Diagnosis, Test Date (site reported results), Test Manufacturer, Time Frozen at -20 C or colder, Time of Draw, Type of Vaccine:, Vaccine manufacturer, Vaccine Name, Was the subject diagnosed with COVID-19 since the last visit?, Was the subject previously diagnosed with COVID-19?

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Adenovirus Antibody, Serum, Bordetella pertussis Antibody, IgG by ELISA, Coxsackie A9 Virus Antibodies, Coxsackie B Virus Antibody Type 1, Coxsackie B Virus Antibody Type 2, Coxsackie B Virus Antibody Type 3, Coxsackie B Virus Antibody Type 4, Coxsackie B Virus Antibody Type 5, Coxsackie B Virus Antibody Type 6, Echovirus Antibody Type 11, Echovirus Antibody Type 30, Echovirus Antibody Type 6, Echovirus Antibody Type 7, Echovirus Antibody Type 9, Haemophilus influenzae b Antibody, IgG, Hologic Panther Fusion SARS-CoV-2/Flu A/B/RSV, Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, Influenza A/B FIA, Influenza B Virus Antibody IgG, Influenza B Virus Antibody IgM, Liaison CMV IgG, Liaison CMV IgM, Mycoplasma Pneumoniae Antibody IgG, Mycoplasma Pneumoniae Antibody IgM, PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel Assay, PolioVirus Antibody Type 1, PolioVirus Antibody Type 3, Xpert Xpress SARS-cov-2/FluA/FluB/RSV

INR

Plasma, Serum

Concomitant Medications (if reported), Donor Blood Type

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, International Normalized Ratio

Insulin

Serum

Lipemia

Plasma, Serum

Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Elevated albumin (Alb) (laboratory evidence), Ethnicity, Gastroenterology Condition, Gender, Lipemia (laboratory evidence), Reported Age, Subject is 18 years of age or older at the time of enrollment and blood draw, Subject receiving treatment, Time of Draw, Treatment or Medication Start Date

Abbott Anti-HCV , Abbott Architect Procalcitonin, Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, ALT, ANA, IgG by IFA, Anti-Nuclear Antibodies (ANA), IgG by ELISA, AST, Cholesterol, Cortisol, C-Reactive Protein, HDL, Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, LDL, NT-Pro BNP, Rheumatoid Factor, Tissue Transglutaminase (tTG) Antibody, IgA, Tissue Transglutaminase Antibody, IgG, Total Bilirubin, Total Protein, Triglycerides

iPTH

Serum

iPTH, TSH

Leishmaniasis

Plasma, Serum, Whole Blood, Urine, Plasma EDTA K3

Date of onset of first symptoms, Leishmaniasis Infection Type, Positive Leishmaniasis Biopsy?, Signs and Symptoms at the Time of Draw.

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Aptima Zika Virus Assay - Plasma, DiaPro Anti-Chikungunya IgG, DiaPro Anti-Chikungunya IgM, DiaPro Zika Virus IgG, InBios Anti-Dengue IgG, InBios Anti-Dengue IgM, InBios Zika IgM Capture , Kalazar Detect Rapid Test for Visceral Leishmaniasis

Lesions

Serum SST, Swabs, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, COVID-19 Vaccination manufacturer, First Dose, COVID-19 Vaccination manufacturer, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of Monkeypox exposure?, Date of Monkeypox test performed?, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Fever Temperature (F), Gender, Has the subject been diagnosed with MonkeyPox, Has the subject received a Monkeypox vaccine?, Has the subject received a Smallpox vaccine?, Has the subject received treatment for Monkeypox?, Is the subject currently symptomatic, Monkeypox test performed?, Monkeypox vaccination date, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Source of Monkeypox exposure?, Stage of Lesions/Scabs?, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Was the subject exposed to Monkeypox, Was the subject previously diagnosed with COVID-19?, Where was the subject exposed to Monkeypox?

ThinPrep Liquid

ThinPrep NILM

Low Risk HIV

Serum, Plasma EDTA K3

Lyme

WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, Plasma EDTA K3

Clinical Observations, Concomitant Medications (if reported), Confirmatory lab results (Tick Born), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date of Tick Bite, Ethnicity, Gender, Height (cm), If pregnant, which trimester?, Location on body of tick exposure, Reported Age, Signs and Symptoms at the Time of Draw., Start time of blood processing, Storage Start Date, Storage Start Time, Subject is 18 years of age or older at the time of enrollment and blood draw, Tick Exposure Site, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Treatment History, Treatment or Medication End Date, Treatment or Medication Start Date, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Anaplasma phagocytophilum (HGA) Ab, IgM, Anaplasma phagocytophilum (HGA) Antibody, IgG, Babesia microfi Ab IgM by IFA, Babesia microti Ab IgG by IFA, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Borrelia burgdorferi Ab, Total ELISA, Borrelia burgdorferi Antibodies, IgG by Immunoblot, Borrelia burgdorferi Antibodies, IgM by Immunoblot, Borrelia burgdorferi IgG, Borrelia burgdorferi IgM, Borrelia Species by PCR (Lyme Disease), DiaSorin Lyme, Ehrlichia chaffeensis Ab, IgG by IFA, Ehrlichia chaffeensis Ab, IgM by IFA, Free PSA (Prostatic Specific Antigen), HIV-1 Viral Load, HSV-2 IgM, Immunetics C6 B.burgdorferi Lyme , Lyme IgG-IgM, Rickettsia typhi (Typhus Fever) Antibody, IgG by IFA, Rickettsia typhi (Typhus Fever) Antibody, IgM by IFA, Total Bilirubin, Total Protein

Measles

Serum, Serum SST, Plasma EDTA K3, Human Cord Serum

City of Origin, Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Ethnicity, Gender, Signs and Symptoms at the Time of Draw., Site Reported Measles Test (IgM by Flocculation), Time DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, BIO-RAD BIOPLEX Measles, LIAISON Measles IgG, LIAISON Mumps IgG, Measles (Rubeola) Antibody, IgM, Measles IgG

Symptoms

Lesion Swab, Plasma, Serum

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, COVID-19 Vaccination manufacturer, First Dose, COVID-19 Vaccination manufacturer, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of Monkeypox exposure?, Date of Monkeypox test performed?, Date of onset of first symptoms, Date of previous COVID-19 diagnosis, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Fever Temperature (F), Gender, Has the subject received a Monkeypox vaccine?, Has the subject received a Smallpox vaccine?, Has the subject received treatment for Monkeypox?, Is the subject currently symptomatic, Monkeypox test performed?, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Source of Monkeypox exposure?, Time Frozen at -20 C or colder, Time of Draw, Was the subject previously diagnosed with COVID-19?, Where was the subject exposed to Monkeypox?

Multiple Myeloma

Plasma

Multiple Sclerosis

Plasma, Serum, Serum SST

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Gender, If pregnant, which trimester?, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Time Frozen at -20 C or colder, Time of Draw, Vaccine manufacturer

Mumps

Serum, Serum SST

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, LIAISON Measles IgG, LIAISON Mumps IgG, LIAISON Rubella IgG, Mumps IgG

Mycoplasma Pneumonia

Plasma

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP

NASH

Plasma EDTA K2, Serum SST, Plasma EDTA K3

Abbott Architect Anti HCV Result, Albumin, Albumin Test Date, Albumin Test Range, Bilirubin, Bilirubin test range, City of Origin, Country of Origin, Date Bilirubin Test Performed, Date of Birth, Date of Consent, Date of Draw, Date of Fibrosis Score, Date sample frozen at -20 C or colder, Ethnicity, Fibrosis Score, Gender, If yes, date performed (Biopsy performed), If yes, stage of biopsy (Biopsy performed), Is the most recent liver biopsy result available?, Prothrombin Date Performed, Prothrombin Time, Reported Age, Sample Storage Temperature, State of Origin, Subject is 18 years of age or older at the time of enrollment and blood draw, Time Frozen at -20 C or colder, Time of Draw

ALT, Architect SARS-CoV-2 IgG, AST

Adult Male, Challenged HIV Neg., Normal Healthy

Serum Non-SST, Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Norgen Saliva RNA, WB EDTA K2, Plasma EDTA K2, Plasma CPDA-1, Whole Blood, WB ACD-A, Throat Swab, WB Na Citrate, Serum SST, Nasopharyngeal swabs, Dry NP Swab, Buccal Swab, Oropharyngeal Swab, Spectrum DNA Saliva, BAL, Plasma CPD, Urine, Nasal Swab, Plasma Na Citrate, Plasma Lithium Heparin, Plasma EDTA K3

Alcohol use?, Amino Acid Substitutions, Blood Type, Buccal Swab Collection Site, City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Date DBS finger prick frozen at -20 C or colder, Date DBS venous frozen at -20 C or colder, Date of Birth, Date of Consent, Date of Draw, Date of Procedure, Date of Surgery, Date sample frozen at -20 C or colder, Diagnosis (Oncology), Did the subject receive a covid-19 vaccination, Distant metastasis location , Does the subject smoke?, Donor Blood Type, Donor HBV Status, Donor HCV Status, Donor HIV Status, Donor is healthy and no history of thyroid disease and has no treatment for thyroid disease., Drug use?, Ethnicity, Examination Procedure (Oncology), Examination Procedure Findings, Extent of spread to the lymph nodes (N), Extent of the tumor (T), Gender, Grade of Cancer, Height (cm), Histologic Type, If pregnant, which trimester?, Nucleotide Deletions, Nucleotide Substitutions, pangoLEARN version, Percent of Genome Coverage, Pre-Existing Medical Conditions, Presence of metastasis (M), Reported Age, SARS-CoV-2 Nextstrain Clade, SARS-CoV-2 PANGOLIN Lineage, Sequencing reference genome (GenBank Accession), Site reported laboratory results, Smoking History, Stage of Cancer, Start time of blood processing, Storage Start Date, Storage Start Time, Subject has symptoms of hypothyroid or thyroid disease, Subject is 18 years of age or older at the time of enrollment and blood draw, Surgical Procedure, Test Date (site reported results), Test Manufacturer, Time DBS finger prick frozen at -20 C or colder, Time DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder, Time of Centrifugation, Time of DBS finger prick, Time of DBS venous, Time of Draw, Time of finger prick, Tumour Location, Vaccine manufacturer, Weight, kg

Abbott Anti-HBs (AUSAB), Abbott Anti-HCV , Abbott Architect Procalcitonin, Abbott HB Core, Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, AdviseDx SARS-CoV-2 IgM, Alanine Aminotransferase, Albumin, Serum or Plasma, Alkaline Phosphatase, Alpha Fetoprotein, Serum (Tumor Marker), Anion Gap, Anti-Mullerian Hormone, Anti-T.cruzi, Aptima Zika Virus Assay - Urine, Architect SARS-CoV-2 IgG, Aspartate Aminotransferase, Bilirubin, Total, Serum or Plasma, BioGX SARS-CoV-2, BUN, Calcium, Serum or Plasma, Candida Antibody IgA, Candida Antibody IgG, Candida Antibody IgM, Carbon Dioxide, Serum or Plasma, Chloride, Serum or Plasma, CMV Antibody IgG, CMV Antibody IgM, COVID-19 IgG, Qualitative by CIA, Creatine Kinase, MB and Relative Percent, Creatinine, Creatinine, Serum or Plasma, DiaSorin Anti-HBe, DiaSorin HBeAg, DiaSorin Zika IgM, EDI COVID-19 IgG, EDI COVID-19 IgM, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM, EuroImmun COVID-19 IgA, EuroImmun COVID-19 IgG, Follicle Stimulating Hormone, GLUCOSE, Glucose, Serum or Plasma, Hematocrit, Hematocrit Count, Hemoglobin, Hepatitis A Virus Antibodies (Total), Hepatitis B Core Ab, Hepatitis B Core Antibodies, Total, Hepatitis B Virus Core Antibody, IgM, Hepatitis B Virus Surface Antibody, Hepatitis Be Virus Antibody, Hepatitis Be Virus Antigen, Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG, HIV 1/2 ab, Immature Platelet Fraction, Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, Influenza B Virus Antibody IgG, Influenza B Virus Antibody IgM, Liaison CMV IgG, Liaison HSV-1 IgG, Liaison HSV-2 IgG, LIAISON Rubella IgG, Liaison SARS-CoV-2 IgM, LIAISON XL SARS-CoV-2 S1/S2 , Luteinizing Hormone, Mean Corpuscular Hemoglobin, Mean Corpuscular Hemoglobin Concentration, Mean Corpuscular Volume, Mean Platelet Volume, NovaTek Malaria Antibody, NovaTek RSV IgG ELISA, Nucleated Red Blood Cell, Nucleated Red Blood Cells %, Perkin Elmer SARS-CoV-2 SALIVA, Perkin Elmer SARS-CoV-2 SWAB, Platelet count, Platelet Count (PLT), Platelet Distribution Width, Potassium, Serum or Plasma, Protein Total, Serum/Plasma, Red Blood Cells (RBC), Rubella Antibody, IgG, Sodium, Serum or Plasma, Soluble Transferrin Receptor, Syphilis, Thyroid Stimulating Hormone, Toxoplasma gondii Ab, IgM, Toxoplasma gondii Antibody, IgG, Troponin I, Urea Nitrogen, Serum or Plasma, Varicella-Zoster Virus Antibody, IgG, Varicella-Zoster Virus Antibody, IgM, White Blood Cells (WBC), WNV RNA, Zika Virus RNA

NT-proBNP

Serum

Date of Draw, Gender, Reported Age

NT-proBNP

Immunosuppressant

WB EDTA K3, Plasma EDTA K3

Country of Origin, Date of Birth, Date of Consent, Date of Draw, Date of Transplant, Ethnicity, Gender, Immunosuppressant Drug, Reported Age, Subject has undergone an organ transplant procedure., Subject is currently taking at least one of the following immunosuppressant drugs: Cyclosporine, Sirolimus, Tacrolimus, or Everolimus., Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Treatment or Medication Start Date, Type of Transplant

Cyclosporine A by Tandem Mass Spectrometry, Ferritin, Sirolimus by Tandem Mass Spectrometry, Soluble Transferrin Receptor, Tacrolimus by Tandem Mass Spectrometry

Osteoarthritis

Plasma, Serum

PBC

Serum SST, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date sample frozen at -20 C or colder, Did the subject receive a covid-19 vaccination, Ethnicity, Fibrosis Score (Choose One), Gender, If pregnant, which trimester?, Is the most recent liver biopsy result available?, Liver Biopsy Date Tested:, Periportal Necroinflammatory Score (Choose one), Portal Inflammation Score (Choose one), Pre-Existing Medical Conditions, Reported Age, Sample Storage Temperature, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Subject is 18 years of age or older at the time of enrollment and blood draw, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw

Alanine Aminotransferase, Albumin, Serum or Plasma, Alkaline Phosphatase, ALT, ANA, IgG by IFA, Anion Gap, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Aspartate Aminotransferase, AST, Bilirubin, Total, Serum or Plasma, Calcium, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Chloride, Serum or Plasma, Creatinine, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Ferritin, Glucose, Serum or Plasma, Potassium, Serum or Plasma, Protein Total, Serum/Plasma, Rheumatoid Factor, Sodium, Serum or Plasma, Soluble Transferrin Receptor, Urea Nitrogen, Serum or Plasma

Newborn, Pediatric, Tanner Stage 4, HIV Pediatric, Tanner Stage 1, Healthy Pediatric

Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, Current HIV Medications (please check all types that apply):, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of HIV diagnosis, Date of Vaccine Administration, Date Performed (HIV-1 Western Blot), Ethnicity, Gender, HIV-1 Western Blot performed?, HIV-1 Western Blot Result, If pregnant, which trimester?, If Yes, How long? years months, Infant Age, NNRTIs, NRTIs, Protease Inhibitors, Reported Age, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Vaccine manufacturer, Vaccine Name

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Alkaline Phosphate, AST, Bio-Rad Geenius HIV 1/2 Supplemental Assay, C-Reactive Protein, EBV VCA IgG, ESTRADIOL, Free T3, Free T4, GGTP, LDH, Lipase, PROGESTERONE, T3-TOTAL, Triglycerides, TSH, Vitamin B12, Vitamin D-25-Hydroxy

Digoxin

Serum

Digoxin

Pregnancy, Healthy Pregnancy, HIV Pregnancy

Plasma, Serum, Plasma EDTA K2, Serum SST, Urine, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Blood Pressure Measurement, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of HIV diagnosis, Date sample frozen at -20 C or colder, Delivery Outcome, Diastolic Blood Pressure, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Does the subject smoke?, Ethnicity, Expected delivery date, Gender, Gender of the fetus, Gestational Age (weeks), Gravidity, Height (cm), History of Chronic Hypertension?, History of Diabetes?, History of pre eclampsia in previous pregnancy, History of Renal Disease, How many times has the subject given birth to a fetus with a gestational age of 20 weeks, If no how many times has the subject been pregnant, If pregnant, which trimester?, Is this the subjects 1st pregnancy, Months Pregnant?, Parity, Pre-Existing Medical Conditions, Proteinuria Assessment Method, Proteinuria result, Reported Age, Sample Hemolysis Level (Qualtex Color Comparator), Site reported laboratory results, Systolic Blood Pressure, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Blood Pressure Measurement, Time of Centrifugation, Time of Draw, Tracking method, Type of pregnancy, Vaccine manufacturer, Was the subject previously diagnosed with COVID-19?, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Alkaline Phosphatase, Alpha Fetoprotein, Serum (Tumor Marker), ALT, Aptima Zika Virus Assay - Serum, Aptima Zika Virus Assay - Urine, Architect SARS-CoV-2 IgG, AST, Beta-hCG, Serum Qualitative, Beta-hCG, Serum Quantitative, Bio-Rad BioPlex 2200 HIV Ag-Ab, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Bordetella pertussis Antibody, IgG by ELISA, CMV Antibody IgG, CMV Antibody IgM, Creatinine, Direct Bilirubin, eGFR, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Ferritin, Free PSA (Prostatic Specific Antigen), Free T3, Free T4, FSH, Haemophilus influenzae b Antibody, IgG, Hematocrit Count, Hepatitis B Core Antibodies, Total, Hepatitis B Virus Core Antibody, IgM, Hepatitis B Virus Surface Antibody, Hepatitis Be Virus Antibody, Hepatitis Be Virus Antigen, Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG, Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgM by ELISA, hGH, HIV-1 Viral Load, Human Chorionic Gonadotropin (hCG), Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, Influenza B Virus Antibody IgG, Influenza B Virus Antibody IgM, Insulin-Like Growth Factor (IGF-1), Liaision SARS-CoV-2 Ab, Liaison CMV IgG, LIAISON Measles IgG, LIAISON Mumps IgG, LIAISON Rubella IgG, Luteinizing Hormone (LH), Mycoplasma Pneumoniae Antibody IgG, Mycoplasma Pneumoniae Antibody IgM, Perkin Elmer SARS-CoV-2 SWAB, Platelet Count (PLT), Progesterone II Gen, Prolactin, Prostatic Specific Antigen, Total, PSA (Prostatic Specific Antigen), Rubella Antibody, IgG, Rubella Antibody, IgM, Testosterone, Thyroxine, Free (Free T4), Total Bilirubin, Total Protein, Toxoplasma gondii Ab, IgM, Toxoplasma gondii Antibody, IgG, Triiodothyronine, Free (Free T3), TSH, Uric Acid, Varicella-Zoster Virus Antibody, IgG

Procalcitonin

Serum CAT, Serum

Abbott Architect Procalcitonin, Borrelia burgdorferi IgG, Borrelia burgdorferi IgM, HSV-1 IgM, HSV-2 IgM, Procalcitonin

Alpha-Feto Protein

Serum

Alpha-Fetoprotein

PSA

Serum

Cryptococcus Ag, PSA (Prostatic Specific Antigen)

SARS-CoV-2, Symptomatic, Respiratory Infection

Liquid Amies, Saliva, Plasma, Serum, Throat Swab, Serum SST, Nasopharyngeal swabs, VTM, Saline, E-Swab, MSC Swab, Nasal Swab, UTM, Plasma EDTA K3, Aptima Swabs, VTM NPS, Sputum

Amino Acid Deletions, Amino Acid Insertions, Amino Acid Substitutions, City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Molecular Test Manufacturer, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Date of Birth, Date of Consent, Date of Draw, Date of onset of first symptoms, Date of Seasonal Influenza Vaccine, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject have an abnormal Chest X-ray, Did the subject have an abnormal EKG, Did the subject have another diagnosis or etiology for their illness?, Did the subject receive a covid-19 vaccination, Did the subject receive a flu vaccine for this season?, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Did the subject Receive non-invasive Ventilation (NIV), Does the subject reside in a congregate care setting?, Ethnicity, Fever Temperature (F), Gender, Height (cm), If pregnant, which trimester?, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Infant Age, Is the subject a healthcare worker?, Is the subject symptomatic as defined by the CDC?, Location of the Worker's Health Center, Nucleotide Deletions, Nucleotide Insertions, Nucleotide Substitutions, pangoLEARN version, Percent of Genome Coverage, Pre-Existing Medical Conditions, Reported Age, SARS-CoV-2 Nextstrain Clade, SARS-CoV-2 PANGOLIN Lineage, SARS-CoV-2 Variant Common Name, Sequencing reference genome (GenBank Accession), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Subjects first COVID19 Molecular Test?, Symptomology at the Time of Diagnosis, Test Date (site reported results), Test Manufacturer, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Type of Vaccine:, Vaccine manufacturer, Vaccine Name, Was the subject admitted to the intensive care unit (ICU)?, Was the subject hospitalized?, Was the subject previously diagnosed with COVID-19?, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, ABBOTT M2000 SARS-CoV-2, Abbott Syphilis TP, AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG, FilmArray Respiratory Panel 2.1, Hologic Panther Fusion SARS-CoV-2, Hologic Panther Fusion SARS-CoV-2/Flu A/B/RSV, Hologic Panther SARS-CoV-2, InBios SARS-CoV-2 IgG, InBios SARS-CoV-2 IgM, Influenza A/B FIA, Liaision SARS-CoV-2 Ab, Liaison SARS-CoV-2 IgM, LIAISON XL SARS-CoV-2 S1/S2 , Methicillin Resistant Staphylococcus aureus, Methicillin-susceptible Staphylococcus aureus, NovaTek Parainfluenza Virus 1, 2, 3 IgG, NovaTek RSV IgG ELISA, Perkin Elmer SARS-CoV-2 SALIVA, Perkin Elmer SARS-CoV-2 SWAB, PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel Assay, RSV FIA

RSV

Saliva, Serum SST, Nasopharyngeal swabs, Saline, Nasal Swab, Plasma EDTA K3, VTM NPS

Change in Concomitant Medications? , Change in underlying medical conditions and/or risk behavior?, City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject develop pneumonia, Did the subject have acute respiratory distress syndrome, Did the subject have an abnormal Chest X-ray, Did the subject have an abnormal EKG, Did the subject have another diagnosis or etiology for their illness?, Did the subject receive a covid-19 vaccination, Did the subject receive ECMO, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Ethnicity, Gender, If pregnant, which trimester?, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Infant Age, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Symptomology at the Time of Diagnosis, Time Frozen at -20 C or colder, Time of Draw, Type of Collection Tube, Vaccine manufacturer, Was the subject admitted to the intensive care unit (ICU)?, Was the subject hospitalized?

FilmArray Respiratory Panel 2.1, PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel Assay, RSV FIA, Xpert Xpress SARS-cov-2/FluA/FluB/RSV

RF

Plasma, Serum, Plasma CPD, Plasma EDTA K3

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Albumin, Calcium, Chloride (Cl), Cholesterol, Direct Bilirubin, Phosphorus, Potassium (K), RA, Sodium (NA), Total Bilirubin, Total Protein, Triglycerides

RA

Plasma, Serum, Serum SST, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Gender, If pregnant, which trimester?, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Treatment History, Treatment or Medication Start Date, Vaccine manufacturer

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Alanine Aminotransferase, Albumin, Serum or Plasma, Alkaline Phosphatase, ALT, ANA, IgG by IFA, Anion Gap, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Aspartate Aminotransferase, AST, Bilirubin, Total, Serum or Plasma, Calcium, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Chloride, Serum or Plasma, Creatinine, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Free Hemoglobin Serum, Glucose, Serum or Plasma, Hepatitis B Virus Surface Antibody, ImmunoConcepts Hep-2000, Immunoglobulin G, Iron, Serum or Plasma, Lex-RALatex, NT-Pro BNP, Potassium, Serum or Plasma, Protein Total, Serum/Plasma, RA, Rheumatoid Factor, Sodium, Serum or Plasma, Urea Nitrogen, Serum or Plasma

Rosacea

Punch Biopsy Skin

Date of Tissue Procurement, Diagnosis (Oncology), Ethnicity, Gender, Gross Description, Microscopic Description, Reported Age, Sample Diameter (mm), Sample Location

RPR

Serum

Rubella, Rubella IgG

Serum, Plasma EDTA K3

Rubella IgG

Screening Population

Saliva, Serum SST, Nasopharyngeal swabs, Plasma EDTA K3

Amino Acid Deletions, Amino Acid Substitutions, City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did the subject receive a covid-19 vaccination, Ethnicity, Fever Temperature (F), Gender, If pregnant, which trimester?, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Is the subject a healthcare worker?, Location of the Worker's Health Center, Nucleotide Deletions, Nucleotide Insertions, Nucleotide Substitutions, pangoLEARN version, Percent of Genome Coverage, Pre-Existing Medical Conditions, Reported Age, SARS-CoV-2 Nextstrain Clade, SARS-CoV-2 PANGOLIN Lineage, Sequencing reference genome (GenBank Accession), Signs and Symptoms at the Time of Draw., Site reported laboratory results, Symptomology at the Time of Diagnosis, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Vaccine manufacturer, Was the subject referred by a healthcare provider?

AdviseDx SARS-CoV-2 IgM, Anti-Mullerian Hormone, Architect SARS-CoV-2 IgG, Follicle Stimulating Hormone, Luteinizing Hormone, Perkin Elmer SARS-CoV-2 SALIVA, Perkin Elmer SARS-CoV-2 SWAB

SLE

Plasma, Serum, Serum SST, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Gender, If pregnant, which trimester?, Pre-Existing Medical Conditions, Reported Age, Rheumatology Condition, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Stage of ATL, State of Origin, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Treatment History, Vaccine manufacturer

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Alanine Aminotransferase, Albumin, Serum or Plasma, Alkaline Phosphatase, ALT, ANA, IgG by IFA, Anion Gap, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Aspartate Aminotransferase, AST, Bilirubin, Total, Serum or Plasma, Calcium, Serum or Plasma, Carbon Dioxide, Serum or Plasma, Chloride, Serum or Plasma, Creatinine, Serum or Plasma, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Ferritin, Free Hemoglobin Serum, Genetic Systems HBsAg EIA 3.0, Glucose, Serum or Plasma, ImmunoConcepts Hep-2000, Immunoglobulin G, Lex-RALatex, NT-Pro BNP, Potassium, Serum or Plasma, Protein Total, Serum/Plasma, Rheumatoid Factor, Sodium, Serum or Plasma, Soluble Transferrin Receptor, Urea Nitrogen, Serum or Plasma

Sodium

Serum

Mycoplasma Genitalium, Chlamydia Trachomatis, Neisseria Gonorrhoeae, STI

Lesion Swab, Vaginal Swab, Rectal Swab, Aptima Swab, ThinPrep Liquid, Aptima Vaginal Swab, Oropharyngeal Swab, Urine, Genital Swabs, Aptima Swabs

City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Ethnicity, Gender, If pregnant, which trimester?, Pre-Existing Medical Conditions, Reported Age, Risk Factors, Sample Source for Site Reported Lab Results, Signs and Symptoms at the Time of Draw., Site reported laboratory results, STI Test name, Subject receiving treatment, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Treatment History, Treatment or Medication End Date, Treatment or Medication Start Date

Aptima BV Assay, Aptima Trichomonas vaginalis Assay, Chlamydia trachomatis, Mycoplasma Genitalium, Neisseria gonorrhoeae

Group B Streptococci, Group A Strep. Sym., Group C Streptococci, Group G Streptococci, S. pyogenes

Throat Swab, Serum SST, Nasopharyngeal swabs, Nasal Swab, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Date of Birth, Date of Consent, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did the subject receive a covid-19 vaccination, Ethnicity, Fever Temperature (F), Gender, If pregnant, which trimester?, In the 14 days prior to illness onset, did the subject have any of the following exposures? , Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site reported laboratory results, Symptomology at the Time of Diagnosis, Test Date (site reported results), Time Frozen at -20 C or colder, Time of Draw, Vaccine manufacturer

Perkin Elmer SARS-CoV-2 SWAB, PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel Assay

Signs/Symptoms Hep.

Plasma, Plasma EDTA K2, Serum SST, Plasma EDTA K3

City of Origin, Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of centrifugation, Date of Consent, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Ethnicity, Gender, Is the subject currently experiencing symptoms of hepatitis infection, One or more of the following within 4 weeks of enrollment: , One or more of the following: , Pre-Existing Medical Conditions, Reported Age, Risk Factors, Signs and Symptoms at the Time of Draw., Subject is 18 years of age or older at the time of enrollment and blood draw, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Two or more of the following within 4 weeks of enrollment:

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, ALT, Architect Anti-HAV IgG, Architect Anti-HAV IgM, Bio-Rad BioPlex 2200 HIV Ag-Ab, Ferritin, Liaison CMV IgG, Liaison CMV IgM, Soluble Transferrin Receptor, Troponin I

Synovial Fluid

Synovial Fluid

Clinical Diagnosis

Cell Count , Lactic Acid Dehydrogenase, Total Protein

Syphilis Prim. UT, Syphilis Lat. T, Syphilis

Plasma, Serum, Serum SST, Plasma EDTA K3

City of Origin, Country of Origin, COVID-19 Vaccination Date, First Dose, COVID-19 Vaccination Date, Second Dose, Covid-19 vaccine booster Manufacturer, Date of Birth, Date of Consent, Date of Covid-19 vaccine booster, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date sample frozen at -20 C or colder, Did subject receive a covid-19 vaccine booster?, Did the subject receive a covid-19 vaccination, Ethnicity, Fever Temperature (F), Gender, Gender of the fetus, Gestational Age (weeks), How many living children do you have, If no how many times has the subject been pregnant, If pregnant, which trimester?, Is this the subjects 1st pregnancy, Pre-Existing Medical Conditions, Reported Age, Signs and Symptoms at the Time of Draw., Site Reported Syphilis RPR Result (flocculation), Symptomology at the Time of Diagnosis, Syphilis Stage of Infection, Syphilis Test Date, Syphilis Test Manufacturer, Syphilis Test Method, Syphilis Test Result, Syphilis Test Type, Syphilis Treatment Status, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Type of pregnancy, Vaccine manufacturer

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, AdviseDx SARS-CoV-2 IgM, Architect SARS-CoV-2 IgG, Bio-Rad BioPlex 2200 HIV Ag-Ab, Liaison CMV IgG, Liaison CMV IgM, Liaison SARS-CoV-2 IgM, LIAISON XL SARS-CoV-2 S1/S2 , RPR (Rapid Plasma Reagin) , Syphilis RPR, V.D.R.L Test

TDA

Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, WB Plasma, Whole Blood, Urine, Plasma EDTA K3

Date of Draw, If pregnant, which trimester?

Aptima Zika Virus Assay - Serum, Aptima Zika Virus Assay - Urine, B. pertussis Ab, IgA by ELISA, B. pertussis Ab, IgM by ELISA, Bordetella pertussis Antibody, IgG by ELISA, Chikungunya Differenciation, Dengue Differenciation, DiaPro Zika Virus IgG, DiaSorin Zika IgM, EuroImmun Anti-Chikungunya Virus IgG, EuroImmun Anti-Chikungunya Virus IgM, Haemophilus influenzae b Antibody, IgG, InBios Anti-Dengue IgG, InBios Anti-Dengue IgM, InBios WNV IgM, InBios Zika IgM Capture , Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, LIAISON Rubella IgG, Mycoplasma Pneumoniae Antibody IgG, Mycoplasma Pneumoniae Antibody IgM, ZIKV Detect 2.0 IgM Capture ELISA

Zika, Toxoplasmosis, Acute Chikungunya, TDS, TDSPL, Malaria, Leptospirosis, Chikungunya

Saliva, WB EDTA K3, Aspirate, WB PAXgene RNA, Plasma, Serum, WB EDTA K2, Plasma CPDA-1, WB Plasma, Whole Blood, Plasma ACD, Serum SST, Amniotic Fluid, Urine, Plasma Na Citrate, Plasma EDTA K3, Human Cord Serum, Umbilical Cord Plasma

City of Origin, Country of Origin, Date of Birth, Date of Consent, Date of Draw, Date of onset of first symptoms, Does the patient have diagnostic testing?, Does the patient have yellow fever vaccination documentation?, Ethnicity, Fever Temperature (F), Gender, If pregnant, which trimester?, Infection Status, Malaria Diagnostics Test Method Used, Malaria Species, Malaria Test Date, Malaria Test Result, Patient Has Documentation For Yellow Fever Vaccination, Pre-Existing Medical Conditions, Pregnant?, Reported Age, Signs and Symptoms at the Time of Draw., State of Origin, Subject has high fever and at least two tropical disease signs and symptoms, Subject is 18 years of age or older at the time of enrollment and blood draw, Suspected Tropical Disease, Suspected Tropical Disease:, Symptomology at the Time of Diagnosis, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Tropical Disease Other Signs and Symptoms, Tropical Disease Signs and Symptoms, Was the subject hospitalized?

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Adenovirus Antibody, Serum, Aptima Zika Virus Assay - Plasma, Aptima Zika Virus Assay - Serum, Aptima Zika Virus Assay - Urine, BinaxNOW Malaria, Bordetella pertussis Antibody, IgG by ELISA, C. pneumoniae IgG, C. pneumoniae IgM Titer, C. psittaci IgG, C. psittaci IgM , C. trachomatis IgG, C. trachomatis IgM, Chikungunya by PCR, Chikungunya Differenciation, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, Dengue Differenciation, Dengue Virus (1-4) Subtype by PCR, DiaPro Anti-Chikungunya IgG, DiaPro Anti-Chikungunya IgM, DiaPro Anti-Dengue Virus IgG, DiaPro Anti-Dengue Virus IgM, DiaPro Zika Virus IgG, DiaPro Zika Virus IgM, DiaSorin Zika IgM, EuroImmun Anti-Chikungunya Virus IgG, EuroImmun Anti-Chikungunya Virus IgM, EuroImmun Anti-Dengue Virus IgG, EuroImmun Anti-Dengue Virus IgM, EuroImmun Anti-WNV IgG, EuroImmun Anti-Zika Virus IgG, EuroImmun Anti-Zika Virus IgM, Haemophilus influenzae b Antibody, IgG, HAV RT-PCR, UltraQual 1000 2x, HIV-1 Viral Load, InBios Anti-Dengue IgG, InBios Anti-Dengue IgM, InBios Chikungunya IgG, InBios Chikungunya IgM, InBios Dengue NS-1, InBios WNV IgG, InBios WNV IgM, InBios Zika IgM Capture , Influenza A Virus Antibody IgG, Influenza A Virus Antibody IgM, Influenza B Virus Antibody IgG, Influenza B Virus Antibody IgM, Leptospira Antibody, IgM by Dot Blot, Malaria Detection and Speciation, Qualitative by RT PCR, Mycoplasma Pneumoniae Antibody IgG, Mycoplasma Pneumoniae Antibody IgM, Syphilis , Temporary Zika NAT, Trypanosoma cruzi, IgG, Trypanosoma cruzi, IgM , WNV-PCR: (Roche WNV-PCR), Zika MAC-ELISA, ZIKV Detect 2.0 IgM Capture ELISA

TPO

Serum

Thyroid Peroxidase

Chronic Lyme Disease, Lyme Disease, Tick-Borne

WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, Serum SST, Punch Biopsy Skin, Plasma EDTA K3

Clinical Observations, Concomitant Medications (if reported), Confirmatory lab results (Tick Born), Country of Origin, Date of Birth, Date of Consent, Date of Diagnosis, Date of Draw, Date of onset of first symptoms, Date of Tick Bite, Ethnicity, Gender, Height (cm), If pregnant, which trimester?, Lipemia (laboratory evidence), Location on body of tick exposure, Reported Age, Sample Hemolysis Level (Qualtex Color Comparator), Signs and Symptoms at the Time of Draw., Start time of blood processing, Storage Start Date, Storage Start Time, Subject is 18 years of age or older at the time of enrollment and blood draw, Tick Exposure Site, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Treatment History, Treatment or Medication End Date, Treatment or Medication Start Date, Weight, kg

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Anaplasma phagocytophilum (HGA) Ab, IgM, Anaplasma phagocytophilum (HGA) Antibody, IgG, Babesia microfi Ab IgM by IFA, Babesia microti Ab IgG by IFA, Borrelia burgdorferi Ab, Total ELISA, Borrelia burgdorferi Antibodies, IgG by Immunoblot, Borrelia burgdorferi Antibodies, IgM by Immunoblot, Borrelia burgdorferi IgG, Borrelia burgdorferi IgM, Borrelia Species by PCR (Lyme Disease), DiaSorin Lyme, Ehrlichia chaffeensis Ab, IgG by IFA, Ehrlichia chaffeensis Ab, IgM by IFA, Immunetics C6 B.burgdorferi Lyme , Rickettsia typhi (Typhus Fever) Antibody, IgG by IFA, Rickettsia typhi (Typhus Fever) Antibody, IgM by IFA

TORCH Negative

Plasma, Plasma Na Citrate

Total Bilirubin

Serum

Total Protein

Serum

Total Protein

BUP, 6AM

Urine

6-Acetylmorphine, Buprenorphine - Urine

Toxo IgG, Toxo IgM

Serum, Plasma EDTA K3

Infection Status, Signs and Symptoms at the Time of Draw., Toxoplasma Gondii IgM (Site Reported CLIA)

Toxoplasma gondii Ab, IgM, Toxoplasma gondii Antibody, IgG

Triglycerides

Serum

Triglycerides

Tropical Disease

WB EDTA K3, Plasma, Serum SST, Plasma EDTA K3

Country of Origin, Date of Birth, Date of Consent, Date of Draw, Date of onset of first symptoms, Does the patient have yellow fever vaccination documentation?, Ethnicity, Gender, If pregnant, which trimester?, Patient Has Documentation For Yellow Fever Vaccination, Reported Age, State of Origin, Suspected Tropical Disease, Time Frozen at -20 C or colder, Time of Centrifugation, Time of Draw, Tropical Disease Signs and Symptoms

Ulcerative Colitis

Plasma EDTA K3

City of Origin, Clinical Symptom Score (CD: CDAI), Concomitant Medications (if reported), Country of Origin, Date of Birth, Date of Consent, Date of CRP result, Date of Diagnosis, Date of Draw, Date of FCP Result, Date sample frozen at -20 C or colder, Disease Status at time of sample collection, Ethnicity, Gastroenterology Condition, Gender, If on medications, for how long? (days), Is the subject currently on medications?, Most recent C-reactive protein (CRP) result, Most recent Fecal Calprotectin (FCP) result, Prior Biologic Treatment History, Reported Age, Subject is 18 years of age or older at the time of enrollment and blood draw, Time Frozen at -20 C or colder, Time of Draw

UTI

Urine

Country of Origin, Date of Draw, Gender, Identity of Bacterial Infection, Infant Age, UTI Bacteria Concentration (CFU) (Site Reported)

Chlamydia trachomatis, Urine Culture

VARPL

Plasma, Plasma Na Citrate

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP

HCV/HIV, HBV/HCV, HBV/HIV

Plasma

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Bio-Rad BioPlex 2200 HIV Ag-Ab

Vitamin D

Serum

Vitamin D-25

VZV, VZVPL

Plasma, Serum, Plasma Na Citrate, Plasma EDTA K3

Anatomical location(s) of fluid filled blisters., Date of Birth, Date of onset of first symptoms, Signs and Symptoms at the Time of Draw., VZV IgM Test Result (Site Reported)

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, Varicella-Zoster Virus Antibody, IgM, VZV IgG

WNV

Plasma, Serum, Plasma CPD, Plasma EDTA K3

Date of Draw

Abbott Anti-HCV , Abbott HBsAg Qualitative, Abbott HIV Ag/AB Combo, Abbott Syphilis TP, InBios WNV IgG, InBios WNV IgM, WNV-PCR: (Roche WNV-PCR)

Candida

Genital Swabs